Tara Man Kadayat

993 total citations
41 papers, 854 citations indexed

About

Tara Man Kadayat is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Tara Man Kadayat has authored 41 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 23 papers in Toxicology and 21 papers in Organic Chemistry. Recurrent topics in Tara Man Kadayat's work include Cancer therapeutics and mechanisms (26 papers), Bioactive Compounds and Antitumor Agents (23 papers) and Synthesis and biological activity (17 papers). Tara Man Kadayat is often cited by papers focused on Cancer therapeutics and mechanisms (26 papers), Bioactive Compounds and Antitumor Agents (23 papers) and Synthesis and biological activity (17 papers). Tara Man Kadayat collaborates with scholars based in South Korea, United States and Switzerland. Tara Man Kadayat's co-authors include Youngjoo Kwon, Eung-Seok Lee, Aarajana Shrestha, Ganesh Bist, Til Bahadur Thapa Magar, Radha Karki, Younghwa Na, Eung-Seok Lee, Eun‐Young Lee and Chanmi Park and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Tara Man Kadayat

41 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Man Kadayat South Korea 20 522 476 201 128 90 41 854
Aarajana Shrestha South Korea 19 334 0.6× 330 0.7× 107 0.5× 95 0.7× 98 1.1× 35 627
Ganesh Bist South Korea 16 290 0.6× 253 0.5× 111 0.6× 78 0.6× 66 0.7× 27 493
Ramya Tokala India 20 783 1.5× 435 0.9× 65 0.3× 84 0.7× 75 0.8× 34 959
Yeh-Long Chen Taiwan 15 308 0.6× 278 0.6× 100 0.5× 80 0.6× 69 0.8× 23 568
Peng‐Cheng Lv China 16 684 1.3× 247 0.5× 68 0.3× 88 0.7× 91 1.0× 26 858
Kishna Ram Senwar India 15 803 1.5× 359 0.8× 61 0.3× 59 0.5× 67 0.7× 17 958
Shalini Nekkanti India 20 633 1.2× 437 0.9× 47 0.2× 63 0.5× 90 1.0× 21 837
Magda A.‐A. El‐Sayed Egypt 18 1.1k 2.2× 501 1.1× 73 0.4× 138 1.1× 205 2.3× 40 1.4k
Mahmoud F. Abo-Ashour Egypt 18 832 1.6× 675 1.4× 73 0.4× 106 0.8× 183 2.0× 22 1.0k
G. Bharath Kumar India 19 695 1.3× 286 0.6× 63 0.3× 75 0.6× 102 1.1× 30 888

Countries citing papers authored by Tara Man Kadayat

Since Specialization
Citations

This map shows the geographic impact of Tara Man Kadayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Man Kadayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Man Kadayat more than expected).

Fields of papers citing papers by Tara Man Kadayat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Man Kadayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Man Kadayat. The network helps show where Tara Man Kadayat may publish in the future.

Co-authorship network of co-authors of Tara Man Kadayat

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Man Kadayat. A scholar is included among the top collaborators of Tara Man Kadayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Man Kadayat. Tara Man Kadayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hwang, Soo‐Yeon, et al.. (2022). Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 60. 128606–128606. 3 indexed citations
2.
Hwang, Soo‐Yeon, Aarajana Shrestha, Seojeong Park, et al.. (2021). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry. 227. 113916–113916. 10 indexed citations
3.
Hwang, Soo‐Yeon, Seojeong Park, Daeun Kim, et al.. (2021). Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison. European Journal of Medicinal Chemistry. 226. 113860–113860. 8 indexed citations
4.
Shrestha, Aarajana, Su‐Jeong Lee, Yong Hyun Jeon, et al.. (2021). Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives. Journal of Medicinal Chemistry. 64(20). 14913–14929. 23 indexed citations
5.
Kadayat, Tara Man, Aarajana Shrestha, Yong Hyun Jeon, et al.. (2020). Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry. 63(18). 10109–10134. 20 indexed citations
6.
Banskota, Suhrid, Nikita Katila, Jaya Gautam, et al.. (2018). Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling. European Journal of Pharmacology. 827. 94–102. 9 indexed citations
7.
Hahn, Dongyup, Dayoung Kim, Tara Man Kadayat, et al.. (2018). Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist. ACS Omega. 3(2). 1970–1976. 5 indexed citations
8.
Kadayat, Tara Man, Suhrid Banskota, Ganesh Bist, et al.. (2018). Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters. 28(14). 2436–2441. 14 indexed citations
9.
Magar, Til Bahadur Thapa, Tara Man Kadayat, Seojeong Park, et al.. (2017). 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent. Bioorganic & Medicinal Chemistry Letters. 27(15). 3279–3283. 20 indexed citations
10.
Karki, Radha, Kyu-Yeon Jun, Tara Man Kadayat, et al.. (2016). A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. European Journal of Medicinal Chemistry. 113. 228–245. 22 indexed citations
11.
Kadayat, Tara Man, Seojeong Park, Til Bahadur Thapa Magar, et al.. (2016). Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Bioorganic Chemistry. 66. 145–159. 13 indexed citations
12.
Park, Seojeong, Tara Man Kadayat, Til Bahadur Thapa Magar, et al.. (2016). Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors. European Journal of Medicinal Chemistry. 125. 14–28. 24 indexed citations
13.
Kadayat, Tara Man, Seojeong Park, Kyu-Yeon Jun, et al.. (2016). Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry Letters. 26(7). 1726–1731. 19 indexed citations
14.
Kadayat, Tara Man, Til Bahadur Thapa Magar, Ganesh Bist, et al.. (2015). Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry. 23(13). 3499–3512. 25 indexed citations
15.
Park, Chanmi, Kyung-Hwa Jeon, Eun‐Young Lee, et al.. (2015). A Series of Novel Terpyridine-Skeleton Molecule Derivants Inhibit Tumor Growth and Metastasis by Targeting Topoisomerases. Journal of Medicinal Chemistry. 58(3). 1100–1122. 97 indexed citations
16.
Karki, Radha, et al.. (2014). Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. European Journal of Medicinal Chemistry. 90. 360–378. 24 indexed citations
17.
Kadayat, Tara Man, Chanmi Park, Til Bahadur Thapa Magar, et al.. (2014). Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity. Bioorganic & Medicinal Chemistry. 23(1). 160–173. 24 indexed citations
18.
Kadayat, Tara Man, et al.. (2014). Thieny/Furanyl-hydroxyphenylpropenones as Inhibitors of LPS-induced ROS and NO Production in RAW 264.7 Macrophages, and Their Structure-Activity Relationship Study. Bulletin of the Korean Chemical Society. 35(8). 2481–2486. 9 indexed citations
19.
Karki, Radha, Tara Man Kadayat, Eun‐Young Lee, et al.. (2012). Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. European Journal of Medicinal Chemistry. 52. 123–136. 58 indexed citations
20.
Karki, Radha, Tara Man Kadayat, Pil-Hoon Park, et al.. (2012). Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study. European Journal of Medicinal Chemistry. 49. 219–228. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026